GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

India · Delayed Price · Currency is INR

2,702.00

+4.80 (0.18%)

Oct 3, 2025, 10:30 AM IST

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2005 - 2019
Pharmaceuticals	37.49B	Log In	Log In	Log In	Log In	Upgrade
Pharmaceuticals Growth	8.56%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2005 - 2019
India	36.99B	Log In	Log In	Log In	Log In	Upgrade
India Growth	9.03%	Log In	Log In	Log In	Log In	Upgrade
Foreign Countries	504.66M	Log In	Log In	Log In	Log In	Upgrade
Foreign Countries Growth	-17.82%	Log In	Log In	Log In	Log In	Upgrade